Cloud Platform for MS Treatment Prediction via Patient Data Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current systems fail to effectively match multiple sclerosis patients with suitable treatment strategies based on prior treatments and their timelines, leading to inefficient treatment selection and progression management due to the heterogeneous nature of the disease and limited representation in clinical trials.
Innovation Solution
A cloud-based application that processes and analyzes large datasets of patient information, including treatment histories and outcomes, to predict the effectiveness of treatments by generating predictions based on similarity analysis and machine learning models, facilitating personalized medicine approaches.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If treatment options are increased to reduce treatment failure, then the likelihood of finding an effective treatment improves, but the time required to determine treatment effectiveness increases
Solution Approach 1:
The system performs preliminary analysis of patient characteristics and treatment history before treatment selection. By pre-processing and storing patient data in structured formats with identified predictive factors, the system enables rapid treatment effectiveness prediction without requiring lengthy trial periods, thus resolving the contradiction between treatment reliability and time loss.
Solution Approach 2:
The system creates virtual replicas of patient profiles by storing and retrieving treatment outcome data from similar patients in the database. By copying and analyzing historical treatment responses from matched patient profiles, the system can predict treatment effectiveness without requiring actual trial treatment time, thereby reducing time loss while maintaining treatment reliability.
2Manufacturing precision
If clinical trial subject groups are restricted by eligibility criteria, then treatment assessment control improves, but the representativeness of trial results to the general patient population decreases
Solution Approach 1:
The system serves multiple functions by maintaining a comprehensive database that includes both controlled clinical trial data and broader real-world patient data. This universal database structure allows the system to provide treatment assessments based on controlled trials while also capturing representativeness from diverse patient populations, resolving the contradiction between assessment control and population representativeness.
Solution Approach 2:
The system acts as an intermediary between clinical trial data and general patient population data. By storing and analyzing both types of data separately yet integratively, the system can translate controlled trial results into applicable recommendations for broader patient populations, maintaining assessment control while improving representativeness.
3Quantity of substance
If patient data is collected from distributed care-provider entities, then data completeness improves, but data processing complexity increases
Solution Approach 1:
The system segments patient data into distinct structured categories including patient characteristics, treatment history, and outcome data. By dividing the comprehensive data collection into organized segments with standardized formats, the system achieves data completeness from distributed sources while reducing processing complexity through systematic data organization and classification.
Data Source
AI summary
Disclosed are systems and methods for building and using a data platform to facilitate intelligent selection of treatments for multiple sclerosis and to identify indications for multiple-sclerosis treatments. Various record snapshots of records associated with multiple sclerosis subjects facilitate efficient queries that can be used to explore heterogeneous, unstructured and non-categorical data sets to generate concrete general hypotheses and subject-specific treatment predictions.